Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 531210 | NSE Symbol : | ISIN : INE923C01011 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Jan-2025	31-Jan-2025	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Friday 31st January 2025 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Next to Fortis Hospital Mulund Link Road Mumbai Maharashtra -400078 inter-alia to consider approve and take on record the Un-Audited Financial Results of the Company for the quarter ended 31st December 2024. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2025 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2024 As required under Regulation 30 of SEBI, we are pleased to submit our Financial Unaudited Results for the Quarter and None Months Ended on 31-12-2024. Kindly take the same on records. (As per BSE Announcement Dated on 31/01/2025)
14-Oct-2024	30-Oct-2024	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Wednesday 30th October 2024 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter and half year ended 30th September2024 We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 30th October, 2024 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September, 2024. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 30th October, 2024 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2024 We would like to inform you that the Board of Director in their meeting held on 30-10-2024 inter alia considered and approve the Unaudited Financial Results for the Quarter Ended 30-9-2024. Kindly take the same on records (As per BSE Announcement Dated on 30/10/2024)
01-Aug-2024	08-Aug-2024	AGM	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation2g(2)& 33 of SEBI (LODR) Regulations2015 is scheduled to be held on Thursday 8th Aug 2024 at 03.30 P.M at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra400078 inter-alia to consider approve and take on record the following agenda; 1. To Consider and approve the Directors Report for the year ended 3Lst March 2024. 2. To Consider and approve the Management Discussion Report Corporate Governance Report CEOs certification & other documents for the year ended 31st March2024. 3. To Consider and approve the Secretarial Audit Report without any disqualification) issued by M/s. Sanjay Dholakia &Associates Practising Company Secretaries for the year ended 31st March2024. The Meeting of Board of Directors was held on Thursday, 8th August, 2024 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board approved Director's Report for the year ended 31st March, 2024. 2. The Board also approved Management Discussion Report, Corporate Governance Report, CEO's certification & other documents for the year ended 31st March, 2024 (As Per BSE Announcement dated on 08.08.2024)
17-Jul-2024	31-Jul-2024	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Wednesday 31st July 2024 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-Audited Financial Results of the Company for the quarter ended 30th June 2024. The Meeting of Board of Directors was held on Monday, 31st July, 2024 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2024 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors (Independent Auditors) have carried out 'Limited Review' of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2024. 2. The Board approved Director's Report for the year ended 31st March, 2024. 3. The Board also approved Management Discussion Report, Corporate Governance Report, CEO's certification & other documents for the year ended 31st March, 2024. The Board Meeting commenced at 3:30 p.m. and concluded at 5.30 p.m. (As per BSE Announcement Dated on 31/07/2024)
04-May-2024	29-May-2024	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regulation 29(2) SEBI (LODR) Regulation 2015. The Board Meeting is scheduled on 29th May2024 for the Approval of Financial Results for the Quarter and Year ended on 31-03-2024 at the registered office of the company at 3.30 pm . Kindly take the same on records . In accordance with Regulation 33 of the Listing Regulations: 1) The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND-AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2024. 2) M/s. Vora & Associates, Chartered Accountants having Firm Regn. No. 111612W, Statutory Auditors have issued an Audit report with unmodified opinion(s) with respect to Audited Standalone Financial Results for the year ended March 31, 2024. 3) Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. The Board Meeting commenced at 03:30 p.m. and concluded at 5:30 p.m. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
10-Jan-2024	31-Jan-2024	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation for the Board Meeting under Regulation 29(2) of SEBI(LODR) Regulation 2015 which will be scheduled on 31-01-2024 at 3.30 pm . We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2024 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2023. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31st Jan, 2024 received from M/s. Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2023. (As Per BSE Announcement dated on 31.01.2024)
14-Oct-2023	31-Oct-2023	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Notice of Board Meeting pursuant to Regulation29(2) of SEBI(LODR) Regulation 2015 for the Quarter and Half Year Ended 30-9-2023 for publishing the Unaudited Financial Results. OUTCOME OF BOARD MEETING HELD ON 31-10-2023 UNDER REGULATION 30 AND 33 OF SEBI(LODR) REGULATION,2015 FOR THE QUARTER EDNED 30-9-2023. (As Per BSE Announcement dated on 31.10.2023)
14-Jul-2023	31-Jul-2023	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2023 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Monday 31st July 2023 at 03.30 P.M at the registered office of the Company at A 101 Pratik Ind Estate Mulund Goregaon Link Road Bhandup West Mumbai- 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter ended 30th June 2023. The outcome of the meeting held on 31-07-2023 for approving the unaudited Quarterly Results for the quarter ended 30-06-2023. and other related matter as mentioned in outcome of the meeting. The Meeting of Board of Directors was held on Monday, 31st July, 2023 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2023 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors (Independent Auditors) have carried out 'Limited Review' of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2023. (As Per BSE Announcement dated on 31.07.2023) As required under SEBI Regulation 33(3) of LODR, 2015, please find the attached Unaudited Financial Results of the Company as on 30-6-2023 approved in the Board meeting held on 31-7-2023. (As per BSE Announcement Dated on 09/08/2023)
03-May-2023	27-May-2023	Accounts	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Saturday 27th May 2023 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter-alia to consider approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31st March 2023. As intimated vide our letter dated 29th March 2023; the trading window for dealing in the securities of the Company is closed from Saturday 01st April 2023 till the second trading day after the Board meeting date i.e. 27th May 2023 for the declaration of financial results for the quarter & financial year ended March 31 2023. In accordance with Regulation 33 of the Listing Regulations: a. The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND- AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2023 together with the Audit Reports with unmodified opinion(s) in respect of Standalone Financial Results, as submitted by the Auditors of the Company. b. Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. The Board Meeting commenced at 03:30 p.m. and concluded at 4.30 p.m. We request you to take the above on record. (As Per BSE Announcement Dated on 27.05.2023)
12-Jan-2023	28-Jan-2023	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2023 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Saturday 28th January 2023 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Next to Fortis Hospital Mulund Goregaon Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter ended 31st December 2022. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 28th January, 2023 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2022. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 28-01-2023 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2022. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 28th January, 2023 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2022. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 28-01-2023 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2022 (As Per BSE Announcement Dated on 28.01.2023)
15-Oct-2022	31-Oct-2022	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2022 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on 31st October 2022 at 03.30 P.M. at the registered office of the Company at A-101 Pratik Industrial Estate Mulund-Goregaon Link Road Mumbai Maharashtra 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter and half year ended 30th September2022. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st October, 2022 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September, 2022. Enclosed herewith the same (Unaudited Financial Results for the quarter and half year ended on 30th September, 2022) along with a Limited Review Report dated 31st October, 2022 issued by M/s. Vora & Associates, Chartered Accountants and Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2022. The Meeting commenced at 3:30 PM and concluded at 4.30 p.m. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st October, 2022 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September, 2022. Enclosed herewith the same (Unaudited Financial Results for the quarter and half year ended on 30th September, 2022) along with a Limited Review Report dated 31st October, 2022 issued by M/s. Vora & Associates, Chartered Accountants and Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2022. The Meeting commenced at 3:30 PM and concluded at 4.30 p.m. (As Per BSE Announcement Dated on 31.10.2022)
14-Jul-2022	30-Jul-2022	Quarterly Results	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2022 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Saturday 30th July 2022 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter-alia - The Meeting of Board of Directors was held on Saturday, 30th July, 2022 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2022 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors have carried out 'Limited Review' of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2022. 2. The Board approved Director's Report for the year ended 31st March, 2022. 3. The Board also approved Management Discussion Report, Corporate Governance Report, CEO's certification & other documents for the year ended 31st March, 2022. 4. And other such agenda as per the attached Results and its Covering letter (As Per BSE Announcement Dated on 30/07/2022)
16-May-2022	28-May-2022	Accounts	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve 1. To approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31-03-2022. This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Saturday 28th May 2022 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. 2. To discuss the feasibility of diversification plans of the Company into chemicals/specialty chemicals. 3. (a) As intimated vide our letter dated 31st March 2022; the trading window for dealing in the securities of the Company is closed from Friday 01st April 2022 till the second trading day after the Board meeting date i.e. 28th May 2022 for the declaration of financial results for the quarter & financial year ended March 31 2022. In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), this is to inform you that the Board of Directors, at its Meeting held today, i.e., 28th May, 2022, has inter alia transacted the following business items (As per BSE Announcement Dated on 28.05.2022) Please find enclosed herewith Newspaper clippings of Audited Financial Results for the quarter and year ended on 31st March 2022 published in FREE PRESS JOURNAL and NAVSHAKTI on 29th May, 2022 in pursuance of Regulation 47(3) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, which were approved in the Board meeting held on 28th May,2022. (As Per BSE Announcement Dated on 30/05/2022)
01-Apr-2022	15-Apr-2022	Forfeiture of Shares	Inter alia to consider and approve forfeiture of partly paid up equity shares of the Company on which the call money is pending as on 1st April,2022 for which 'Final Demand cum Forfeiture Notice' was sent by speed post to all such partly paid shareholders vide Company letter dated 1st March, 2022 and published in newspapers on 4th March, 2022. NOTICE is hereby given that the Board of directors of the company at their meeting held on 15th April 2022 have forfeited 20,51,900 partly paid Equity Shares of Rs. 10 each on account of non-payment of Allotment amount due from the concerned shareholders. A list of shareholders with details, whose equity shares have been forfeited is placed on website of the Company i.e. www.findoc-cll.in (WWW.FINDOC-CLL.IN). Public are advised to take note of the same and not to transact on any partly paid up shares of the Company. The shareholders who hold partly paid equity shares have been requested to return the Original share certificates to the Company for cancellation. The Company has already cancelled all such equity shares after forfeiture. If anybody transact in those forfeited shares, the Company shall not be responsible to such transactions (As Per BSE Announcement dated on 15.04.2022)
18-Feb-2022	28-Feb-2022	Forfeiture of Shares	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/02/2022 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) of SEBI (LODR) Regulations 2015 is scheduled to be held on Monday 28th February 2022 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Goregaon Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter alia to consider and approve forfeiture of partly paid up equity shares of the Company on which the call money is still pending receipt even after several reminders; after giving a final reminder to such shareholders and following the prescribed procedure.

1 2

LOGIN HERE

Colinz Laboratories Ltd

Board Meeting